YOUNG WILLIAM D 4
4 · Praxis Precision Medicines, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Praxis (PRAX) Director William D. Young Receives Stock Award
What Happened
William D. Young, a director of Praxis Precision Medicines (PRAX), received two equity awards on June 10, 2026: 1,371 restricted stock units (RSUs) and 648 derivative units. Both grants were non-cash awards reported at $0.00 per share (standard for RSU/derivative awards); no shares were sold. These are compensation awards, not open-market purchases or sales.
Key Details
- Transaction date: 2026-06-10; Form 4 filed 2026-06-12 (timely filing).
- Awards: 1,371 RSUs (reported as A, $0.00) and 648 derivative units (reported as A, $0.00).
- Shares owned after transaction: not specified in the filing.
- Footnote highlights:
- The 1,371 RSUs convert to one share each and vest in a single installment on the earlier of June 10, 2027 or the issuer’s 2027 annual meeting. (F1)
- The 648 derivative award vests in 12 equal monthly installments starting July 10, 2026, through June 10, 2027 (or earlier if the 2027 meeting occurs). (F2)
- No indication of tax-withholding sale, 10b5-1 plan, or late filing.
Context
- RSUs and derivative awards are non-cash director compensation that will convert to common stock as they vest; they do not by themselves indicate buying or selling intent.
- The derivative award’s monthly vesting means shares will be delivered over roughly a one-year period if vesting conditions are met.
- For retail investors, director grants are routine corporate governance/compensation events; track future Form 4 filings for any sales or additional disclosures.
Insider Transaction Report
Form 4
YOUNG WILLIAM D
Director
Transactions
- Award
Common Stock
[F1]2026-06-10+1,371→ 3,269 total - Award
Stock Option (Right to Buy)
[F2]2026-06-10+648→ 648 totalExercise: $240.66Exp: 2036-06-10→ Common Stock (648 underlying)
Footnotes (2)
- [F1]Mr. Young was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact|2026-06-12